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Abstract
Background: Initial reports of 23Na magnetic resonance imaging (MRI) date back to the 1970s. However, methodological
challenges of the technique hampered its widespread adoption for many years. Recent technical developments
have overcome some of these limitations and have led to more optimal conditions for 23Na-MR imaging. In order
to serve as a reliable tool for the assessment of clinical stroke or brain tumor patients, we investigated the
repeatability and reproducibility of cerebral sodium (23Na) imaging in healthy subjects.
Methods: In this prospective, IRB approved study 12 consecutive healthy volunteers (8 female, age 31 ± 8.3)
underwent three cerebral 23Na-MRI examinations at 3.0 T (TimTrio, Siemens Healthineers) distributed between
two separate visits with an 8 day interval. For each scan a T1w MP-RAGE sequence for anatomical referencing and
a 3D-density-adapted, radial GRE-sequence for 23Na-imaging were acquired using a dual-tuned (23Na/1H) head-
coil. On 1 day, these scans were repeated consecutively; on the other day, the scans were performed once. 23Na-
sequences were reconstructed according to the MP-RAGE sequence, allowing direct cross-referencing of ROIs.
Circular ROIs were placed in predetermined anatomic regions: gray and white matter (GM, WM), head of the
caudate nucleus (HCN), pons, and cerebellum. External 23Na-reference phantoms were used to calculate the
tissue sodium content.
Results: Excellent correlation was found between repeated measurements on the same day (r2 = 0.94), as well as
on a different day (r2 = 0.86). No significant differences were found based on laterality other than in the HCN (63.
1 vs. 58.7 mmol/kg WW on the right (p = 0.01)). Pronounced inter-individual differences were identified in all
anatomic regions. Moderate to good correlation (0.310 to 0.701) was found between the readers.
Conclusion: Our study has shown that intra-individual 23Na-concentrations in healthy subjects do not
significantly differ after repeated scans on the same day and a pre-set time interval. This confirms the
repeatability and reproducibility of cerebral 23Na-imaging. However, with manual ROI placement in
predetermined anatomic landmarks, fluctuations in 23Na-concentrations can be observed.
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Background
Initial reports of 23Na magnetic resonance imaging
(MRI) date back to the 1970s [1]. However, methodo-
logical challenges of the technique – low SNR due to
low in-vivo sodium concentrations and low available
field strengths – hampered its widespread adoption for
many years. Recent technical developments such as
clinical 3 Tesla MRI, improved coils, and faster gradients
have overcome some of these limitations and have led to
more optimal conditions for 23Na-MR imaging. Several
recent publications have demonstrated the feasibility of
23Na-MRI for in-vivo imaging of physiological condi-
tions in the kidney [2–4], cartilage and musculoskeletal
system [5–8], heart [9–11], and prostate [12].
The use of 23Na-MRI for imaging of the brain was first
described in 1983 by Hilal et al., who observed changes
following an induced stroke in a cat model [13]. In 1987,
Turski et al. utilized the technique in patients with a
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: melissa.ong@gmx.de
1Institute of Clinical Radiology and Nuclear Medicine, Medical Faculty
Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167
Mannheim, Germany
Full list of author information is available at the end of the article
Meyer et al. BMC Medical Imaging           (2019) 19:26 
https://doi.org/10.1186/s12880-019-0324-6
cerebral neoplasm [14]. Since then, several feasibility
studies [15, 16] have utilized 23Na-MRI for the imaging
of stroke [17–19], demyelinating diseases [20], and brain
tumors. In the latter case, various brain tumors exhibit
increased sodium concentrations relative to normal brain
structures [21–23]. Theoretically, this observation is based
on the presence of cell membrane depolarization prior to
cell division. Since cell division is increased in neoplasia,
intracellular sodium concentration (ISC) is thus increased
and consequently the total 23Na-concentration rises [24].
Therefore, 23Na-MRI could be useful for predicting thera-
peutic tumor response in brain [22] or other organs [25].
In order to serve as a reliable tool for the assessment
of clinical stroke or brain tumor patients, studies have to
investigate the absolute levels and differences of sodium
concentrations in healthy volunteers undergoing con-
secutive MRIs with a dual-tuned (23Na/1H) head-coil at
different time points. Thus, the objective of this study
was to verify the repeatability and reproducibility of
cerebral 23Na-MR imaging in healthy subjects.
Methods
This study was performed without any financial or
non-financial support from industry. The authors had
complete control of the data submitted for publication.
The local institutional review board (IRB) and ethics com-
mittee (Medical Ethics Committee II Mannheim,
Germany; reference number: 2013 566 N – MA) approved
this prospective baseline study which was performed in
accordance with the ethical standards laid down in the
1964 Declaration of Helsinki and its later amendments.
Healthy volunteers
After the procedure was fully explained, written in-
formed consent was obtained from all participants prior
to MR imaging. Twelve healthy volunteers (8 females, 4
males, mean age 31 ± 8.3 years) underwent three brain
MRI examinations (V1–3,) spread between two separate
visits with an interval of 8 days between. During one
visit, two consecutive, repetitive scans (V1 and V2) were
obtained. During a time gap of 5 min in between the two
scans the subject was moved out of the gantry. The iso-
center was identical to the prior examination using the
scanner’s dedicated laser positioning device. At the sec-
ond visit, only one examination was performed. The
subject was positioned in a similar position according to
anatomic landmarks and the isocenter was again set
using the scanner’s dedicated laser positioning device.
The group was subdivided randomly, whereby one half
of the subjects received two MRI scans during the first
visit and one MRI during the second visit. The other half
of the subjects received one MRI on the first visit and
two MRIs on the second visit. Besides the standard ex-
clusion criteria for MRI (i.e. pacemaker), patients with a
history of brain lesions or neurological symptoms
were excluded. For both visits, the subjects were
scheduled at the same time of the day (to exclude in-
fluences of circadian rhythm changes of sodium con-
centrations [26]) and were asked to abstain from the
consumption of alcohol and coffee for eight hours
prior to the exams.
Brain MRI
All MR examinations were performed on a 3.0 T
MR-system (Siemens TimTrio; Siemens Healthineers,
Erlangen, Germany). Individuals were positioned supine
and head first in a dual-tuned (23Na/1H) radiofrequency
(RF) coil (Rapid Biomedical, Germany). In addition to
the survey sequences, the imaging protocol included the
following sequence protocol: standard morphological,
axial T2 weighted images; axial fluid attenuated inver-
sion recovery (FLAIR) images; diffusion-weighted im-
aging (DWI) based on echo planar imaging; T1 weighted
magnetization-prepared rapid acquisition gradient-echo
(MP-RAGE) for anatomical referencing, and a three di-
mensional (3D)-density-adapted projection reconstruction
23Na-sequence [27]. No contrast media was administered.
Sequence details are summarized in Table 1. Echo time
was defined as the time period between the middle of the
excitation pulse and the beginning of the readout. A cylin-
drical falcon tube with a 0.6% NaCl reference was placed
within the field of view as a concentration reference.
Quantification of sodium concentration
23Na-MRI images were co-registered offline to the
corresponding T1 weighted MP-RAGE image for each
volunteer using the statistical parametric mapping
Table 1 Sequence parameters
T1w MP-RAGE 3D-DPR-GRE 23Na
TR (msec) 1630 120
TE (msec) 3.4 0.2
Projections NA 17,000
Samples/projection NA 369
Radial fraction p NA 0.20
Bandwidth 179 NA
Readout time (msec) NA 20
Inversion time (msec) 900 NA
Flip angle (°) 9 87
Spatial resolution (mm3) 1 × 1 × 1 3.6 × 3.6 × 3.6
Field of view (mm2) 256 × 256 NA
Sections 160 NA
b-value NA NA
Note: NA not applicable, TR repetition time, TE echo time, MP-RAGE =
magnetization-prepared rapid acquisition gradient-echo, 3D-DPR-GRE 3D-
density adapted radial gradient echo
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toolbox (SPM8, The Wellcome Trust Centre for Neuro-
imaging, London) of MATLAB (R2010a, The Math-
Works Inc., Natick, MA). Data sets of every patient were
analyzed on an OsiriX DICOM viewer 3.8.1 (OsiriX
Foundation, Geneva, Switzerland). A quantitative assess-
ment of 23Na-concentration was performed by two radi-
ologists (reader 1 and 2 with 6 and 2 years experience in
23Na-imaging, respectively) who independently, manu-
ally placed predetermined, identically-sized (0.508 cm2)
circular region of interests (ROIs) on three consecutive
slices according to the following specific anatomic land-
marks: the bilateral central gray (centrum semiovale)
and temporal white matter (GM/WM), the bilateral
heads of the caudate nuclei, the pons at the level of the
superior cerebellar pedunculi, and the bilateral cerebel-
lum within the pedunculi cerebelli medius. These ROIs
were placed on every examination. An example of a ROI
placement is shown in Fig. 1. The ROIs were placed on
the morphological 1H images (MP-RAGE) and after-
wards copied onto the 23Na-images. Values for
23Na-concentration in millimoles per kilogram wet
weight were calculated according to the following
formula:
Na½ tiss ¼
SNa tiss
SNa ref
Na½ Ref x
1− exp −
TR
Tref1
 !
1− exp −
TR
Ttiss1
 
x
alfa x exp −
TE
Tref2 f
 !
þ beta x exp − TE
Tref2s
 !
alfa x exp −
TE
Ttiss2 f
 !
þ beta x exp − TE
Ttiss2s
 
where [Na] is sodium concentration, tiss is tissue, ref. is
reference phantom, SNa is signal intensity of sodium, f is
fast, s is slow, TE is echo time, TR is repetition time,
alfa/beta is 0.6/0.4 for brain tissue [28] and 0.0/1.0 for
CSF.
With:
T2ref/f = 7.15 msec, T2ref/s = 33.7 msec
Brain: T2tiss/f = 4 msec, T2tiss/s = 29 msec and
T1tiss/s = 29 msec
CSF: T2tiss/s = 55 msec and T1tiss = 58.1 msec
Statistical analysis
JMP 10.0 (SAS Institute Inc., Cary, North Carolina,
USA) was used for statistical analysis. Descriptive
statistics (median, mean, 95% confidence interval
and standard deviation (SD)) were used for all data.
For the analysis of repeatability and reproducibility
of cerebral 23Na-concentrations, repeatability was de-
fined as repeated exams on the same day (V1 and
V2) with the same experimental setup, whereas re-
producibility was defined as a repeated exam (V3)
with a pre-set time interval of 8 days. Repeatability
and reproducibility analyses were performed using a
Pearson’s momentum correlation. Intra-individual
23Na-concentrations in specific ROIs were tested
with repeated measures ANOVA using a Dunnett’s
test. Chi-squared tests were performed for subgroup
analysis in terms of the left versus the right hemi-
sphere. P values less than 0.05 were considered sta-
tistically significant. A normal distribution was
confirmed using a Kolmogorov-Smirnov test (0.019
< p < 0.622). Due to the data scale, Spearman’s rho
tests were chosen to determine the inter-reader
correlation.
Fig. 1 Left: Example of region-of-interest (ROI) placement in the head of the caudate nucleus on a 23Na-image; right: T1 MP-RAGE as an
anatomical reference image
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Results
Quantification of 23Na-concentration
The overall mean 23Na-concentration (in millimoles per
kilogram wet weight) for both readers and sides was
51.5 ± 4.5 mmol/kg WW and 40.9 ± 3.8 mmol/kg WW
for the respective gray and white matter, 60.9 ± 8.1
mmol/kg WW for the head of the caudate nucleus, 39.8
± 5.3 mmol/kg WW for the pons, and 40.1 ± 4.9 mmol/
kg WW for the cerebellum. Subgroup analysis compar-
ing the left and right hemisphere did not reveal statisti-
cally significant differences other than in the head of the
caudate nucleus. 23Na-concentrations of the head of the
caudate nucleus were 63.1 ± 8.4 mmol/kg WW on the
left compared to 58.7 ± 7.3 mmol/kg WW on the right
(p = 0.01) (Fig. 2).
Inter-individual 23Na-fluctuations
Pronounced inter-individual differences were identified
in all anatomic regions. The max/min 23Na concentra-
tion values and maximum percentage differences were:
Gray matter = 65.4/42.4 mmol/kg WW (35.1%), white
matter 52.9/34.5 mmol/kg WW (34.7%), caudate head =
81.5/49.5 mmol/kg WW (39.3%), pons = 58.4/33.2 mmol/
kg WW (43.0%), and cerebellum 52.3/33.0 mmol/kg
WW (36.9%).
Repeatability analysis: intra-individual 23Na-
concentrations
Excellent correlation (r2 = 0.94) was found between re-
peated measurements on the same day (V1 and V2). An
example of two consecutive images is shown in Fig. 3.
Overall, the mean 23Na-concentration measured at V1
and V2 were not significantly different (V1: 52.7 ± 20.7
mmol/kg WW vs V2: 53.2 ± 20.8 mmol/kg WW; p >
0.05). Similarly, there was no significant difference
across all anatomic regions between measurements at
V1 and V2 (compare Table 2; p > 0.05). The order of the
MRI examinations (two examinations at the first or the
second appointment) had no significant influence on the
23Na-concentration (0.206 < p < 0.886).
Reproducibility analysis: intra-individual 23Na-
concentrations
Excellent correlation (r2 = 0.86) was found between V1
and V3 measurements. Overall, mean 23Na-concentra-
tions measured at V1 and V3 were not significantly dif-
ferent (V1: 52.7 ± 20.7 mmol/kg WW vs V2: 53.1 ± 21.6
mmol/kg WW; p > 0.05). Similarly, there were no signifi-
cant differences across the anatomic regions between
measurements of V1 and V3 (compare Table 2; p > 0.05).
When comparing the maximum and the minimum
values for the 23Na-concentration, the mean percentage
of intra-individual differences ranged from 6.5% (GM)
and 10% (Pons).
Inter-reader agreement
Moderate to good correlation (0.310 to 0.701) was found
between the two readers. Overall, the mean 23Na-con-
centration as measured for the different anatomic re-
gions by reader 2 was greater than that measured by
reader 1 (see Fig. 4). The largest discrepancies were seen
in the gray matter and in the head of the caudate (47.4
Fig. 2 Top: First examination (V1) on the first examination day with 23Na-image, T1 MP-RAGE and DWI (from left to right); bottom: Second
examination (V2) on the first examination day
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vs. 55.5 mmol/kg WW and 56.0 vs. 65.8 mmol/kg WW,
respectively; p > 0.05).
Discussion
The potential of 23Na-MRI for brain imaging in onco-
logical and non-oncological applications remains to be
ultimately determined [29]. To further implement
23Na-MRI in clinical neuroimaging, particularly in the
setting of oncological follow-up, certain fundamental re-
quirements are to be fulfilled. One of these is the
intra-individual reliability and reproducibility of brain
23Na-concentrations on consecutive MR examinations.
Little published data are available regarding the
23Na-concentrations of healthy gray and white matter,
but the values of the current study are in the range
described in the literature [20, 21, 30]. This study
showed no significant asymmetries in the 23Na-concen-
trations of several predefined areas of the human brain,
other than between the left and right caudate head.
These differences could be attributed to partial vol-
ume effects of the immediately adjacent cerebrospinal
fluid (CSF). The relatively narrow head of the caudate
nucleus impeded the manual ROI placement, which
could explain these differences. One way to poten-
tially solve this problem is by normalization of the
data to a reference brain data set, as done in psych-
iatry studies for hippocampus volume measurements
and the use of semi-automatic segmentation tools.
Statistically significant intra-individual differences
were neither seen between two consecutive MR
exams nor between MR exams separated temporally
by 8 days. This supports the repeatability and repro-
ducibility of cerebral 23Na-MRI. However, per-patient
differences in sodium concentration were as high as
10%, depending on the anatomic region. This poten-
tial bias should be considered in any further
Fig. 3 Total 23Na-concentrations with standard deviations (SD) according to laterality (GM = gray matter; WM =white matter; HCN = head of the
caudate nucleus); * indicates significant difference with p = 0.01
Table 2 Repeatability and Reproducibility of 23Na concentrations
TSC Repeatability Reproducibility
Region V1 V2 p-value V1 V3 p-value
GM 51.0 ± 6.3 51.5 ± 6.7 0.77 51.0 ± 6.3 52.0 ± 7.2 0.72
WM 40.5 ± 4.8 41.2 ± 4.4 0.30 40.5 ± 4.8 41.0 ± 6.3 0.83
HCN 59.9 ± 9.9 61.1 ± 9.7 0.54 59.9 ± 9.9 61.7 ± 10.9 0.41
Cerebellum 40.5 ± 7.7 40.6 ± 5.0 0.44 40.5 ± 7.7 39.2 ± 5.7 0.39
Brainstem 41.1 ± 10.2 39.4 ± 6.8 0.80 41.1 ± 10.2 40.0 ± 7.9 0.93
CSF 102.1 ± 21.6 103.8 ± 20.9 0.93 102.1 ± 21.6 103.6 ± 24.5 0.98
Mean 52.7 ± 20.7 53.2 ± 20.8 0.68 52.7 ± 20.7 53.1 ± 21.6 1.0
Note: TSC = total sodium concentration; V1/V2 = repeated exams on the same day; V1/V3 = exam on different dates
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longitudinal or follow up study. Nevertheless, future
studies may benefit from an intra-individual longitu-
dinal approach, since inter-individual differences at a
single time point can reach over 30%. Another im-
portant consideration for the clinical implementation
of brain 23Na-MRI would be the development of a
simple evaluation method for 23Na-MRI imaging with
sufficient inter-reader reliability. The inter-reader reli-
ability in this study was moderate but not perfect;
however, this may be explained in part by the differ-
ences in clinical 23Na-MRI experience between the
readers (6 vs. 2 years). As previously mentioned, a
semi-automatic segmentation tool could facilitate this
assessment and decrease inter-reader variability. In
general, several future avenues may benefit from a
broader clinical implementation of 23Na-MRI. Accur-
acy and quantification of 23Na concentrations between
different research facilities, hospitals, and techniques
(e.g. UTE, radial or cones scheme [31]) should be
confirmed. Double-tuned coils seem to be the ideal
instrument for 23Na-imaging enabling the appropriate
fusion of 1H- and 23Na-images. Although the reliabil-
ity of the current technique appears to be sufficient,
this potential (small) for bias should be taken into ac-
count within further studies. While intra-individual
comparison seems acceptable for assessment of 23Na
concentration, biases may arise due to natural
inter-individual differences, and further follow-up
studies are necessary. Finally, future semi-automatic
segmentation tools as proposed could help to partially
overcome biases due to inter-reader interpretative
differences.
Limitations
Our study had a number of limitations. Since it was ini-
tiated as a baseline study, the study group was relatively
small and young without any known medical conditions.
To evaluate the true clinical value of this technique, fur-
ther evaluations in longitudinal studies will be necessary
both in healthy volunteers as well as in patients.
Conclusion
Our study has shown that intra-individual 23Na-concen-
trations in healthy subjects do not significantly differ
after repeated scans on the same day and a pre-set time
interval. This confirms the repeatability and reproduci-
bility of cerebral 23Na-imaging and serves as a baseline
for future studies. However, with manual placement of
ROIs in predetermined anatomic landmarks, fluctuations
in 23Na-concentrations can be observed. This must be
taken into account if 23Na-imaging is to be considered
as a potential tool for therapeutic monitoring.
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Fig. 4 Bland-Altman plot, plotting the ratio of the two readers versus the average of both readers. The lines and given numbers on the right side
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